Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash and Cash Equivalents, at Carrying Value	$ 23,350	$ 25,088
Accounts receivable, net of allowance for doubtful accounts	197,163	201,322
Inventories, net	43,371	46,821
Prepaid Expense, Current	14,246	13,128
Income Taxes Receivable, Current	10,980	5,294
Other Assets, Current	12,710	12,215
TOTAL CURRENT ASSETS	301,820	303,868
Property, Plant and Equipment, Net	149,014	138,824
INTANGIBLES, net	10,642	10,949
GOODWILL	164,464	163,337
Deferred Tax Assets, Net, Noncurrent	3,876	4,452
Other Assets, Noncurrent	45,837	39,580
TOTAL ASSETS	675,653	661,010
CURRENT LIABILITIES:
Accounts payable	47,084	50,821
Accrued payroll and related costs	34,617	38,969
Taxes other than payroll and income	11,199	6,979
Unearned revenues	11,009	10,887
Income taxes payable	8,333	14,462
Other accrued expenses	19,624	13,657
TOTAL CURRENT LIABILITIES	131,866	135,775
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	356,000	267,002
DEFERRED COMPENSATION	42,705	38,014
Deferred Tax Liabilities, Noncurrent	7,210	8,870
Other Liabilities, Noncurrent	43,879	41,960
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common Stock, Value, Issued	1,174	1,203
Additional paid-in capital	0	0
Retained Earnings (Accumulated Deficit)	415,906	415,930
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,894)	(8,626)
Treasury shares (at cost)	(317,613)	(245,184)
Total Core Laboratories N.V. shareholders' equity	87,573	163,323
Stockholders' Equity Attributable to Noncontrolling Interest	6,420	6,066
TOTAL EQUITY	93,993	169,389
TOTAL LIABILITIES AND EQUITY	$ 675,653	$ 661,010